COVID-19 Oral Antivirals
(Paxlovid/ Lagevrio)​
The COVID 19 has been a major public health issue the past several years. To combat this problem, California legislature has passed regulation to allow pharmacist to furnish oral antiviral such as Paxlovid and Lagevrio. If you believe you are having COVID 19 symptoms and are within the high risk population for developing severe COVID 19, you may be eligible for oral antiviral. Please see the tables below for COVID 19 symptoms and a list of conditions that place you in the high risk category.
​
​
​
​
List of Conditions Predisposing Patient to Severe COVID-19 Infection
Preventing and managing COVID-19 is important for public health. COVID-19 spreads mainly through respiratory droplets from an infected person when they cough, sneeze, or talk. To reduce the risk of infection, individuals should follow good hygiene practices, like washing hands often with soap for at least 20 seconds or using hand sanitizer with at least 60% alcohol when soap isn’t available. It is also important to avoid touching the face.
Wearing masks in crowded or enclosed spaces helps block the virus. Social distancing, keeping at least six feet apart, is also crucial. Getting vaccinated and staying updated on booster shots is one of the best ways to prevent severe illness.
If someone contracts COVID-19, they should self-isolate to prevent spreading it, monitor their symptoms, and seek medical help if symptoms worsen. Managing the infection through rest, hydration, and medications can help recovery.
​
​
​
If you would like a free Covid-19 oral antiviral consultation, please download and fill out the consent form and upload it to our secured email at phong.lieu@pharmdprescriptions.com. Please also upload a photo of your positive Covid-19 antigen test if available. For additional information on Paxlovid and Lagevrio, click on the links below review the drug fact sheets.
Drug Fact Sheets
Consent Form
Abstracted from the Center for Disease Control.